R. Suematsu

发表

Systemic Lupus Erythematosus: Genomics, Mechanisms, and Therapies

H. Inoue, Y. Tada, A. Ohta, 2012 .

Phenotyping of P105-Negative B Cell Subsets in Patients with Systemic Lupus Erythematosus

H. Inoue, Y. Tada, S. Koarada, 2011, Clinical & developmental immunology.

Functional disturbance of the stress-adaptation system in patients with scleroderma

H. Inoue, Y. Tada, Tsukasa Kuroki, 2011 .

Functional disturbance of the stress-adaptation system in patients with scleroderma

H. Inoue, Y. Tada, Tsukasa Kuroki, 2011, Modern rheumatology.

[A case of cutaneous Mycobacterium nonchromogenicum infection suggesting sarcoidosis association].

H. Inoue, Y. Tada, S. Koarada, 2010, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

Cyclosporin A treatment for Japanese patients with severe adult-onset Still’s disease

H. Inoue, Y. Tada, S. Koarada, 2009, Modern rheumatology.

Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still’s disease?

Y. Arinobu, Y. Tada, S. Koarada, 2018, Rheumatology International.

Identification of lipophilic ligands of Siglec5 and -14 that modulate innate immune responses

Yasunobu Miyake, S. Yamasaki, T. Miyamoto, 2019, The Journal of Biological Chemistry.

[Case of microscopic polyangiitis and giant cell arteritis after influenza vaccination].

H. Inoue, Y. Tada, S. Koarada, 2011, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

A case of granulomatosis with polyangiitis accompanied with strawberry gingivitis, and a review of the literatures

Y. Tada, Y. Tokuda, S. Koarada, 2018 .

Therapeutic response of patients with adult Still’s disease to biologic agents: multicenter results in Japan

T. Horiuchi, H. Inoue, Y. Ishigatsubo, 2012, Modern rheumatology.

Nocardiosis in adult-onset Still's disease and vasculitis syndrome.

H. Inoue, Y. Tada, M. Fukuoka, 2008, The American journal of the medical sciences.

The balance between Foxp3 and Ror-γt expression in peripheral blood is altered by tocilizumab and abatacept in patients with rheumatoid arthritis

Y. Tada, Y. Tokuda, Y. Nakao, 2016, BMC Musculoskeletal Disorders.

Toll-like receptor homolog RP 105 modulates the antigen-presenting cell function and regulates the development of collagen-induced arthritis

H. Inoue, K. Miyake, Y. Tada, 2015 .

Toll-like receptor homolog RP105 modulates the antigen-presenting cell function and regulates the development of collagen-induced arthritis

H. Inoue, K. Miyake, Y. Tada, 2008, Arthritis research & therapy.

Autoantibody-producing RP105(-) B cells, from patients with systemic lupus erythematosus, showed more preferential expression of BCMA compared with BAFF-R than normal subjects.

H. Inoue, Y. Tada, S. Koarada, 2010, Rheumatology.

Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.

T. Mak, S. Kondo, H. Inoue, 2011, Arthritis and rheumatism.

Increased RP105-Negative B Cells in IgG4-Related Disease

Y. Tada, S. Koarada, A. Ohta, 2013, The open rheumatology journal.

Successful golimumab therapy in four patients with refractory Takayasu’s arteritis

Y. Tada, S. Koarada, A. Ohta, 2018, Modern rheumatology.

[BCMA and autoantibody-producing RP105 B cells; possible new targets of B cell therapy in systemic lupus erythematosus].

H. Inoue, Y. Tada, S. Koarada, 2012, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still’s disease?

Y. Arinobu, Y. Tada, S. Koarada, 2018, Rheumatology International.

Persistent expression of CXCR5 on plasmablasts in IgG4-related disease

Y. Tada, Y. Tokuda, S. Koarada, 2015, Annals of the rheumatic diseases.